Diagnostic Kits/Testing new ground

From Commons Based Research
< Diagnostic Kits
Revision as of 12:06, 24 September 2009 by Mac (talk | contribs) (New page: * Field of Molecular Diagnostics is expanding from disease detection to include Prognostics (prediction of disease risk) and tests for a patients response to treatment. Lots of discoverie...)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
  • Field of Molecular Diagnostics is expanding from disease detection to include Prognostics (prediction of disease risk) and tests for a patients response to treatment. Lots of discoveries of new genetic targets and biomarkers enabled by genomics and proteomics.
  • Biomarkers may be indicators of disease as well as potential drug targets
  • Molecular Diagnostic market revenue: 2001- $1.2B; 2007- $4.2B? (actually an over-optimistic estimate)
Retrieved from "http://cyber.harvard.edu/commonsbasedresearch/?title=Diagnostic_Kits/Testing_new_ground&oldid=4231"